2014-05-30

[DIV28M] Suggestions for Plenary Speaker for the 2015 American Psychological Association Convention: Please send by Wed June 4th

Hi everyone,

I am currently on the Board of Convention Affairs of the APA.  In that role, we are in charge of selecting and inviting plenary speakers.
These plenaries feature high-profile single speakers (psychologist or non-psychologist) that would appeal to a broad audience of psychologists (practice, policy, science).  They need to be dynamic speakers.  Despite that, we also cannot offer the speakers any honorarium; they generally only get economy travel, accommodation and waiver of registration.

I am having to prepare a list of potential speakers for our group to start considering so if you have some suggestions I would appreciate that.  Please send me their name, institution, area of expertise, whether or not you know they are a good speaker and ideally a link so that we can find out more about the person.  International speakers are discouraged in part due to the cost of airfare.

Please DO NOT contact the person - we are just in the early stages of creating a list of potential speakers for the group to review.

Many thanks,

Suzette Evans


Suzette M. Evans, Ph.D.
Professor of Clinical Neurobiology and Research Scientist VI
Director of the Women's Research Center
Editor, Experimental and Clinical Psychopharmacology
College of Physicians and Surgeons of the Columbia University Medical Center and the New York State Psychiatric Institute
1051 Riverside Drive
Unit 66, Room 3704
New York NY 10032

Voice: 646-774-6136
Fax: 646-774-6141


IMPORTANT NOTICE: This e-mail is meant only for the use of the intended

recipient. It may contain confidential information that is legally privileged

or otherwise protected by law. If you received this e-mail in error or from

someone who was not authorized to send it to you, you are strictly prohibited

from reviewing, using, disseminating, distributing or copying the e-mail. PLEASE

NOTIFY US IMMEDIATELY OF THE ERROR BY RETURN E-MAIL AND DELETE THIS MESSAGE FROM YOUR SYSTEM. Thank you for your cooperation.











2014-05-29

[DIV28SUPER] Final reminder: Proposed changes to membership bylaws- please review

Greetings members,

The voting for proposed changes to the Division 28 bylaws will end
tomorrow (5/30). If you would still like to vote, please see the changes
(and clarification) outlined below and email me by 5 pm tomorrow with your
vote.

1. Allowing Division 28 membership to be directly available through the
online membership portal: ______

2. Change in requirement for Members/Associate Members to have a doctoral
degree in psychology or a substantially related field: (Note that this
change does not impact student and affiliate members) _____



Warm regards,
Kelly Dunn
Division 28 Secretary

---
Kelly Dunn, Ph.D.
Assistant Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P: 410-550-2254; F: 410-550-0030






-----Original Message-----
From: Kelly Dunn <kdunn9@jhmi.edu>
Date: Monday, May 19, 2014 8:30 AM
To: "DIV28M@lists.apa.org" <DIV28M@lists.apa.org>
Subject: Clarification to proposed changes to membership bylaws- please
review

Greetings members,

I would like to clarify that students and other affiliate members are not
impacted by the second proposal to change the requirement for Members to
have a doctoral degree in psychology or a substantially related field.
That proposal impacts only Fellows, Members, and Associate Members, so the
membership requirements for student and affiliate membership will not be
changed. Below are the existing bylaws for affiliate and student members.

If this changes the status of your previous vote, please let me know.

Warm regards,
Kelly Dunn

---
In addition to the regular membership classes, there shall be three
classes of Affiliates, who are not Members of APA: Affiliate,
Distinguished Affiliate, and
Corporate Affiliate. They shall have all rights and privileges of
membership; they shall receive the Division Newsletter and be eligible to
subscribe to the Division members-only electronic list. The Executive
Committee (EC) may from time to time review Corporate Affiliates (who
could be both an individual member and corporate liaison). If, during
such review, a conflict of interest is believed to exist, the EC shall
first discuss the conflict and then may vote whether to limit specific
rights or privileges of a Corporate Affiliate. A decision to limit any
right or privilege of a Corporate Affiliate must pass with a majority of
EC members present for the vote. The Corporate Affiliate shall be
notified.

Affiliates shall be those individuals who are Student Affiliates of APA
(undergraduate or graduate students, as defined in Article II of the
Bylaws of the APA); other graduate
students actively involved in research or clinical psychopharmacology; and
persons who are not members of the APA, but who have equivalent
qualifications in psychology or in neuroscience, pharmacology or
physiology, and whose work is related to advancing a fuller understanding
of drugs and behavior.


Distinguished Affiliates shall be those who are not Members of APA, but
who are outstanding scientists in psychology, pharmacology, neuroscience,
or physiology, whose work is related to advancing a fuller understanding
of drugs and behavior. Distinguished Affiliates are elected by a majority
vote of the voting members of the Executive Committee pending the majority
approval of the Members voting in a regular business meeting.
Distinguished Affiliates will have all rights and privileges granted other
Affiliates in the Division.

---

---
Kelly Dunn, Ph.D.
Assistant Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P: 410-550-2254; F: 410-550-0030






-----Original Message-----
From: Kelly Dunn <kdunn9@jhmi.edu>
Date: Friday, May 16, 2014 12:57 PM
To: "DIV28M@lists.apa.org" <DIV28M@lists.apa.org>
Subject: Proposed changes to membership bylaws- please review

Greetings Division 28 Members,

Attached to this email you will find the existing Division bylaws (April
2013) and a set of revised Division bylaws (May 2014) with two changes
proposed. The changes are highlighted in yellow for you to review. The
proposed changes are related to the new online portal through which
individuals can apply for APA membership. The first change would allow
persons signing up as an APA member to choose to become a member of
Division 28 at the time of APA membership enrollment, with dues being
collected from them at that time. The proposed member would only become a
division member if they meet the requirements of becoming an APA member;
therefore the second change is that the requirements for being a Member
and Associate Member of Division 28 include a doctoral degree in
psychology or a substantially related field, which would make our Division
requirements consistent with existing APA membership requirements.

Please consider adopting the proposed changes to Division 28 bylaws.
Please review these changes and respond to me (kdunn9@jhmi.edu),
indicating your vote ("Yes" or "No") in the spaces provided below for each
of the proposed changes by Friday, May 30, 2014.

Allowing Division 28 membership to be directly available through the
online membership portal: ______

Change in requirement for Members/Associate Members to have a doctoral
degree in psychology or a substantially related field: _____



Kind regards,
Kelly Dunn
Division 28 Secretary

---
Kelly Dunn, Ph.D.
Assistant Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P: 410-550-2254; F: 410-550-0030

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2014-05-21

[DIV28SUPER] Three funding announcements

Announcement of National Longitudinal Study of Neurodevelopmental Consequences of Substance Use - See more at: http://grants.nih.gov/grants/guide/notice-files/NOT-DA-14-011.html#sthash.gqdwMMr9.dpuf

 

Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R33) - See more at: http://grants.nih.gov/grants/guide/pa-files/PAR-14-231.html#sthash.9Ylakfvw.dpuf

 

Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33) - See more at: http://grants.nih.gov/grants/guide/pa-files/PAR-14-230.html#sthash.ejKnNKV4.dpuf

 

 

 

 

 

Glen

 

Glen D. Morgan, Ph.D. 
Psychologist

Tobacco Control Research Branch
Behavioral Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute

9609 Medical Center Dr.

MSC 9761, 3E136

Bethesda, MD 20892-9761

       (FedEx, UPS & other couriers: please use Rockville, MD  20850 instead of Bethesda)

Phone:  240-276-6787

Email: gmorgan@nih.gov

 

 

2014-05-20

[DIV28SUPER] FACULTY POSITION AT UNIV OF CHICAGO

The University of Chicago has a new opening for a mid/senior level faculty position in tobacco/smoking population science on the tenure track or with tenure (depending on candidate’s background).

 

Our goal is to expand and build upon our current strengths in neurosciences, biobehavioral, and clinical research. We are seeking someone with expertise in tobacco and smoking research, to compliment and build on our work in behavioral and modifiable risk factors for cancer prevention and control (nicotine/tobacco, alcohol, obesity, stress, etc.).  See description below.   

 

Please contact me if you have any questions or would like to know more about the position.  Feel free to pass on to colleagues.

 

Sincerely,

--Andrea King

 

Andrea King, Ph.D.

Research Section Chief and Mission Director

Professor, University of Chicago, Department of Psychiatry &
    Behavioral Neuroscience

Director, Clinical Addictions Research Laboratory

5841 S. Maryland Avenue (MC-3077)

Chicago, IL 60637

TEL: 773-702-6181

PAGE: 773-753-1880, p7567

FAX: 773-702-0096

  

 

 

FACULTY POSITION AVAILABLE

 

The University of Chicago Comprehensive Cancer Center, an NCI-designated comprehensive cancer center, invites candidates to apply for a tenure-track/tenured fully-funded faculty position in population-based clinical science,  epidemiology, genetic epidemiology, or psychopharmacology. The rank of appointment and academic department will be commensurate with qualifications, experience and academic field. Applicants must have a doctoral degree in epidemiology, psychology, or a related social science field or an MD with training in clinical research or epidemiology. The successful candidates will be expected to secure external support for research.

The University of Chicago offers outstanding opportunities for research in cancer by providing state-of-the-art research resources encompassing: attractive start-up and benefit packages, renovated or new dry and wet laboratory spaces, access to patient recruitment core, high throughput genomic facilities, biostatistical/bioinformatics support, and clinical data/biospecimen repositories from multiethnic populations.

To apply, visit the University of Chicago Academic Career Opportunities website at academiccareers.uchicago.edu/applicants/Central?quickFind=52821.

A cover letter and curriculum vitae are required to apply.  For questions and more information, contact Drs. Andrea King 773.702.6181, or Habibul Ahsan 773.834.9956.

Review of applications will begin in May 2014 and will continue until the position is filled.

   The University of Chicago is an Affirmative Action / Equal Opportunity Employer.

 

 

 

 


This email is intended only for the use of the individual or entity to which it is addressed and may contain information that is privileged and confidential. If the reader of this email message is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is prohibited. If you have received this email in error, please notify the sender and destroy/delete all copies of the transmittal.

Thank you.

2014-05-19

[DIV28M] Clarification to proposed changes to membership bylaws- please review

Greetings members,

I would like to clarify that students and other affiliate members are not
impacted by the second proposal to change the requirement for Members to
have a doctoral degree in psychology or a substantially related field.
That proposal impacts only Fellows, Members, and Associate Members, so the
membership requirements for student and affiliate membership will not be
changed. Below are the existing bylaws for affiliate and student members.

If this changes the status of your previous vote, please let me know.

Warm regards,
Kelly Dunn

---
In addition to the regular membership classes, there shall be three
classes of Affiliates, who are not Members of APA: Affiliate,
Distinguished Affiliate, and
Corporate Affiliate. They shall have all rights and privileges of
membership; they shall receive the Division Newsletter and be eligible to
subscribe to the Division members-only electronic list. The Executive
Committee (EC) may from time to time review Corporate Affiliates (who
could be both an individual member and corporate liaison). If, during
such review, a conflict of interest is believed to exist, the EC shall
first discuss the conflict and then may vote whether to limit specific
rights or privileges of a Corporate Affiliate. A decision to limit any
right or privilege of a Corporate Affiliate must pass with a majority of
EC members present for the vote. The Corporate Affiliate shall be
notified.

Affiliates shall be those individuals who are Student Affiliates of APA
(undergraduate or graduate students, as defined in Article II of the
Bylaws of the APA); other graduate
students actively involved in research or clinical psychopharmacology; and
persons who are not members of the APA, but who have equivalent
qualifications in psychology or in neuroscience, pharmacology or
physiology, and whose work is related to advancing a fuller understanding
of drugs and behavior.


Distinguished Affiliates shall be those who are not Members of APA, but
who are outstanding scientists in psychology, pharmacology, neuroscience,
or physiology, whose work is related to advancing a fuller understanding
of drugs and behavior. Distinguished Affiliates are elected by a majority
vote of the voting members of the Executive Committee pending the majority
approval of the Members voting in a regular business meeting.
Distinguished Affiliates will have all rights and privileges granted other
Affiliates in the Division.

---

---
Kelly Dunn, Ph.D.
Assistant Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P: 410-550-2254; F: 410-550-0030






-----Original Message-----
From: Kelly Dunn <kdunn9@jhmi.edu>
Date: Friday, May 16, 2014 12:57 PM
To: "DIV28M@lists.apa.org" <DIV28M@lists.apa.org>
Subject: Proposed changes to membership bylaws- please review

Greetings Division 28 Members,

Attached to this email you will find the existing Division bylaws (April
2013) and a set of revised Division bylaws (May 2014) with two changes
proposed. The changes are highlighted in yellow for you to review. The
proposed changes are related to the new online portal through which
individuals can apply for APA membership. The first change would allow
persons signing up as an APA member to choose to become a member of
Division 28 at the time of APA membership enrollment, with dues being
collected from them at that time. The proposed member would only become a
division member if they meet the requirements of becoming an APA member;
therefore the second change is that the requirements for being a Member
and Associate Member of Division 28 include a doctoral degree in
psychology or a substantially related field, which would make our Division
requirements consistent with existing APA membership requirements.

Please consider adopting the proposed changes to Division 28 bylaws.
Please review these changes and respond to me (kdunn9@jhmi.edu),
indicating your vote ("Yes" or "No") in the spaces provided below for each
of the proposed changes by Friday, May 30, 2014.

Allowing Division 28 membership to be directly available through the
online membership portal: ______

Change in requirement for Members/Associate Members to have a doctoral
degree in psychology or a substantially related field: _____



Kind regards,
Kelly Dunn
Division 28 Secretary

---
Kelly Dunn, Ph.D.
Assistant Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P: 410-550-2254; F: 410-550-0030

__________________ Div28m@lists.apa.org ___________________
restricted to APA members subscribers corner: http://lists.apa.org

2014-05-16

[DIV28SUPER] Request for Information (RFI): Availability of Data and Samples from Randomized Smoking Cessation Trials NOT-DA-14-005

Request for Information (RFI): Availability of Data and Samples from Randomized Smoking Cessation Trials

http://grants.nih.gov/grants/guide/notice-files/NOT-DA-14-005.html  has been extended to May 19  http://grants.nih.gov/grants/guide/notice-files/NOT-DA-14-010.html


Notice Number: NOT-DA-14-005

Update: The following update relating to this announcement has been issued:

  • May 8, 2014 - Notice to Extend the Response Date for the NOT-DA-14-005 "Request for Information (RFI). See Notice NOT-DA-14-010.

Key Dates
Release Date: March 11, 2014
Response Date: May 19, 2014

Related Announcements
None

Issued by
National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)

Purpose

The National Institute on Drug Abuse and the National Cancer Institute seek information about the availability of data and biological samples from randomized controlled trials of smoking cessation therapies.

Background

Despite a significant reduction in the number of people who smoke, smoking continues to be a leading cause of premature death in the United States.   Forty-four million Americans continue to smoke with 440,000 premature deaths occurring each year.  Eighty percent of those who attempted to quit on their own, without pharmacological or behavioral therapies, relapsed within the first month, with only 3% still abstinent at 6 months.  Only 15 to 35% of individuals remain abstinent for a year with pharmacological interventions such as nicotine replacement therapy (NRT), bupropion, and varenicline.

Recent findings suggest that nicotinic receptor subunit risk variants in the CHRNA5/A3/B4 cluster within the chromosome 15q25 locus are associated with failed quit attempts; delay in quitting; early cancer diagnosis than non-risk allele counterparts.  Many of these risk variants are more prevalent in European Americans and rarer in African Americans, which may have implications for the generalizability to a larger ethnically diverse population.  Based on the nicotine metabolite ratio (NMR) along with CYP2A6 genotype, smokers can be categorized into slow and fast metabolizer categories.  Slow metabolizers receive little benefit from pharmacotherapies like bupropion, while NRT's like the patch offer suitable cessation aides.  Conversely, fast nicotine metabolizers seem to receive good benefit from varenicline.

Personalized medicine strategies to treat nicotine addiction based on these findings may now help to increase the effectiveness of existing pharmacotherapies.   Still questions remain on whether the results for the CHRNA5/A3/B4 cluster variants, CYP2A6 variants, and NMR biomarker can be moved to the clinic.  Genetic analysis from other smoking cessation trials is needed to validate these results in different population.  Samples from existing clinical trials are needed to conduct whole genome wide association analysis to identify other gene variants that are predictors of smoking cessation response to pharmacotherapies and/or those susceptible to the deleterious consequences of smoking, such as lung disease, cancer, and heart disease.

Information Requested

The National Institute on Drug Abuse and the National Cancer Institute seek information about the availability of data and/or biological samples from randomized controlled trials of smoking cessation therapies.   If you have conducted a randomized clinical trial, we request that you send information about the clinical trial.  Examples of the type of information that would be helpful include:  1) The Program Director/Principal Investigator and Assistant contact information; 2) publication and or clinical trial registry IDs; 3) the number of trial participants randomized with data available for intent-to-treat analysis; 4) the types of bio-specimens available and the number of research participants with these bio-specimens  5) the number of bio-specimens or DNA samples with data available for intent-to-treat analyses; 6) amount of DNA available per research participant; 7) trial design characteristics; 8) Baseline demographics and behavior; 9) trial Sponsors

The information gathered will assist in evaluating the feasibility of combining data and samples for a pharmacogenomics analysis of smoking cessation based on the availability of these samples. 

Submitting a Response

All responses must be submitted via email to smokingcessation@nih.gov by May 1, 2014.  Please include the Notice number in the subject line. Response to this RFI is voluntary. Responders are free to address any or all of the categories listed above. The submitted information will be reviewed by the NIH staff.

This request is for information and planning purposes only and should not be construed as a solicitation or as an obligation on the part of the Federal Government. The NIH does not intend to make any awards based on responses to this RFI or to otherwise pay for the preparation of any information submitted or for the Government's use of such information.

The NIH will use the information submitted in response to this RFI at its discretion and will not provide comments to any responder's submission. However, responses to the RFI may be reflected in future funding opportunity announcements. The information provided will be analyzed and may be aggregated in reports. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.  No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

Inquiries

Please direct all inquiries to:

Jonathan D. Pollock, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1309
Email:  jpollock@mail.nih.gov

 

 

-------------------------

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to istserv@list.nih.govmailto:listserv@list.nih.gov,

 Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

[DIV28M] Proposed changes to membership bylaws- please review

Greetings Division 28 Members,

Attached to this email you will find the existing Division bylaws (April
2013) and a set of revised Division bylaws (May 2014) with two changes
proposed. The changes are highlighted in yellow for you to review. The
proposed changes are related to the new online portal through which
individuals can apply for APA membership. The first change would allow
persons signing up as an APA member to choose to become a member of
Division 28 at the time of APA membership enrollment, with dues being
collected from them at that time. The proposed member would only become a
division member if they meet the requirements of becoming an APA member;
therefore the second change is that the requirements for being a Member
and Associate Member of Division 28 include a doctoral degree in
psychology or a substantially related field, which would make our Division
requirements consistent with existing APA membership requirements.

Please consider adopting the proposed changes to Division 28 bylaws.
Please review these changes and respond to me (kdunn9@jhmi.edu),
indicating your vote ("Yes" or "No") in the spaces provided below for each
of the proposed changes by Friday, May 30, 2014.

Allowing Division 28 membership to be directly available through the
online membership portal: ______

Change in requirement for Members/Associate Members to have a doctoral
degree in psychology or a substantially related field: _____



Kind regards,
Kelly Dunn
Division 28 Secretary

---
Kelly Dunn, Ph.D.
Assistant Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P: 410-550-2254; F: 410-550-0030




__________________ Div28m@lists.apa.org ___________________
restricted to APA members subscribers corner: http://lists.apa.org

[DIV28SUPER] FW: Overview of PROMIS, Neuro-QOL, & NIH Toolbox Webinar




From: "nihpromiscommunications@nihpromis.airws.org" <nihpromiscommunications@nihpromis.airws.org>
Reply-To: "info@nihpromis.org" <info@nihpromis.org>
Date: Friday, May 16, 2014 9:25 AM
Subject: Overview of PROMIS, Neuro-QOL & NIH Toolbox Webinar

PROMIS Announcement - June 10 Webinar

Having trouble viewing this email? View in your browser.

PROMIS News, funded by the National Institutes of Health
May 16, 2014

Advances in Person-Centered Outcome Measurement:
An Overview of PROMIS, Neuro-QOL,
and the NIH Toolbox

Webinar
Tuesday, June 10, 2014

 

Time (CDT)

Topic

Speaker

09:00 – 10:00 am

Overview of person-centered outcome instruments from PROMIS, Neuro-QOL, and NIH Toolbox

Nan Rothrock, PhD

10:00 – 11:00 am

Introduction to item response theory and computer adaptive testing

Richard Gershon, PhD

11:00 – 11:30 am

Data collection options

Monica Prudencio, BA

09:00 – 10:00 am.

Overview of person-centered outcome instruments from PROMIS, Neuro-QOL, and NIH Toolbox

Nan Rothrock, PhD

Registration

To register, email help@assessmentcenter.net with “webinar” in the subject line. Please include the following information.

  • Full name
  • Institution
  • Brief statement about your area of interest (e.g., clinical condition, age group, domain/construct)

You will receive a confirmation with information about logging in to the webcast. There is no cost to participating in this event. Space is limited and will be offered on a first come, first serve basis. The session will be recorded for viewing at a later date.

Patient Reported Outcomes Measurement Information System (PROMIS), funded by the NIH, is a system of highly reliable, precise measures of patient–reported health status for physical, mental, and social well–being. PROMIS tools measure what patients are able to do and how they feel by asking questions. PROMIS’ measures can be used as primary or secondary endpoints in clinical studies of the effectiveness of treatment.

Follow us on Twitter@promisNIH. twitter

HHS logo    NIH logo

news illustration
You are receiving this e-mail notification because you had registered to download PROMIS short forms, or gave permission to the PROMIS Network to send you periodic e-mails. If you do not wish to receive additional notifications, please enter your e-mail address as it appears on messages from us, at http://www.nihpromis.org/Researchers/unsubscribe.aspx. If you experience any difficulty or have questions, please contact us at info@nihpromis.org or call 1–888–261–0922. You are currently subscribed as kdunn9@jhmi.edu kdunn9@jhmi.edu.

2014-05-12

[DIV28SUPER] Fwd:Pre-convention Workshop on Scientific Integrity


From Sangeeta Panicker, APA Scientific Affairs, spanicker@apa.org.  Please share with your divisions if you'd like.

 

 

Trouble viewing this email? View online.
 

APA Pre-convention Workshop on Scientific Integrity

The day-to-day activities of research present ethical decisions and judgments that are often not discussed openly. This workshop, co-sponsored by the APA Education and Science Directorates, brings together graduate students, post-doctoral fellows and research faculty to learn how to engage in productive, open conversations about scientific integrity on a daily basis.

Participants will:

  • Engage in small group discussions and case studies designed to explore ethical subtleties and nuances in the conduct of research;
     
  • Learn how to begin open conversations about scientific integrity in practical research settings, that go beyond simply addressing "regulatory compliance " issues; and,
     
  • Bring back skills to their home institution to encourage ongoing, day-to-day discussions about scientific integrity, so as to prevent misconduct and uphold scientific integrity.

Who should attend? Anyone conducting research -- be it with humans or other animals. This includes students, fellows, and faculty. Although groups from the same laboratory are especially encouraged to attend, a single member from a laboratory may also attend.

APA Pre-convention Workshop on Scientific Integrity
Day: August 06, 2014
Fees: Faculty - $100; Post-doctoral Fellow - $75; Graduate Student - $50
Enrollment Limit: 40

 

For more information, and to register for the event click here.

SPACE IS LIMITED - REGISTER NOW!

 

You are receiving this one-time message from

The APA Science and Education Directorates
The American Psychological Association
750 First Street, NE
Washington, DC 20002-4242

 

Click on this link to unsubscribe from this list UNSUBSCRIBE

An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list..

2014-05-03

[DIV28SUPER] NYTimes: Some E-Cigarettes Deliver a Puff of Carcinogens

http://nyti.ms/1iVJMTo

New research suggests that some e-cigarettes get so hot that they can produce a carcinogenic byproduct.


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2014-05-02

[DIV28SUPER] FW: Election Alert Notice!


This is a reminder to vote in this year’s election for Division Officers and State/Provincial Association (SPTA) Council Representatives.  Voting members of the Divisions and SPTAs received an email on April 15 from APA announcing the 2014 Division-SPTA elections.  Reminders will be emailed every Tuesday to those who have not yet voted.  The email you received contains a link to your ballot.  You may also access your ballot by visiting my.apa.org.  You will need to login to access your member profile page.  Use the link titled “2014 Division-SPTA Election” to access your ballot.  Once you access your ballot, you can view a candidate’s statement by clicking on their name.  The election will close May 29.

 

If you did not receive an email announcing the election, please contact the APA Election Office at gcoad@apa.org or by phone at 202 336-6087.

 

Happy Voting!

APA Election Office